NYC Dept. Health / Mental Hygiene Screening for Depression

NYC Dept. Health / Mental Hygiene Screening for Depression
– designed to ensure the entire US population ranks as depressed

NYC Dept. Health / Mental Hygiene Screening for Depression
– designed to ensure the entire US population ranks as depressed
NIH: Public Servant or Private Marketer? NIH Seeks Outside Inquiry of Alzheimer’s researcher conflicts of interest – LAT Mon, 31 Jan 2005 A year after the Los Angeles Times published its first an in-depth investigative report documenting in detail evidence of major conflicts of interest by top scientists at the…
Children in "Hot Demand" for Clinical Trials May 31, 2002 FYI Rachel Zimmerman of The Wall Street Journal reports about the "frenzy" to recruit children for drug trials. The inclusion of children in drug trials allows pharmaceutical companies to cash in on six month patent exclusivity extensions worth hundreds of millions of dollars….
UK Health Dept/ British Prime Minister/ Issue Statement Warning No PAXIl for Children! Tue, 10 Jun 2003 UK GOVERNMENT STATEMENT: Press release: reference 2003/0223 Tuesday 10th June 2003 Related Story: GlaxoSmithKline discloses link to serious undesirable effects in depressed children and adolescents under age 18 SEROXAT MUST NOT BE USED…
Canadian Regulators Withdraw ADD Drug Linked to 20 Sudden Deaths Thu, 10 Feb 2005 Canadian regulators – but not the FDA – have withdrawn a Adderall, a pssychostimulant drug prescribed for children with so-called ADHD that has been linked to 20 sudden deaths linked to the drug – of which…
Antidepressant Makers Withhold Data on Children – Washington Post Thu, 29 Jan 2004 A front page article in The Washington Post addresses the key issue undermining public health and safety. Drug companies conceal unfavorable clinical trial findings: the tests failed to demonstrate that antidepressants are either safe or beneficial for…
Free Academic Drug Tests – NYT Editorial Delivers Fatal Blow to Leaders of Psychiatry Tue, 30 Nov 2004 Today’s editorial in The New York Times is a follow-up to yesterday’s solid report by Barry Meier, that focused on the culpability of academic researchers and their prestigious medical institutions in undermining…